The Indian Polycap Study (TIPS). Lancet 2009 Mar 30 [Epub]

Trial profile The number of people screened for eligibility was not recorded. BP=blood pressure. HR=heart rate

The Indian Polycap Study (TIPS). Lancet 2009 Mar 30 [Epub]

Baseline characteristics

The Indian Polycap Study (TIPS). Lancet 2009 Mar 30 [Epub]

Reasons for permanent discontinuation of study drugs

The Indian Polycap Study (TIPS). Lancet 2009 Mar 30 [Epub]

Selected adverse effects

The Indian Polycap Study (TIPS). Lancet 2009 Mar 30 [Epub]

Rates of discontinuation of study drug by categories of reasons

The Indian Polycap Study (TIPS). Lancet 2009 Mar 30 [Epub]

Mean changes in systolic blood pressure (SBP) and diastolic blood pressure (DBP)

The Indian Polycap Study (TIPS). Lancet 2009 Mar 30 [Epub]

Changes in systolic blood pressure (SBP) and diastolic blood pressure (DBP) after randomisation over time

Most of the reduction in blood pressure was detected early and was sustaineduntil the end of active treatment.

As=aspirin. T=thiazide. R=ramipril.At=atenolol. S=simvastatin. P=Polycap.

*End of treatment.

The Indian Polycap Study (TIPS). Lancet 2009 Mar 30 [Epub]

Changes in lipids in each of the nine groups

The Indian Polycap Study (TIPS). Lancet 2009 Mar 30 [Epub]

Changes in heart rate compared with baseline

The Indian Polycap Study (TIPS). Lancet 2009 Mar 30 [Epub]

Changes in urinary 11-dehydrothromboxane B2 concentrations

The Indian Polycap Study (TIPS). Lancet 2009 Mar 30 [Epub]

Changes in blood pressure in subgroups based on baseline systolic blood pressure (A), diabetes (B), and use of calcium-channel blockers (C)

The Indian Polycap Study (TIPS). Lancet 2009 Mar 30 [Epub]

Changes in LDL cholesterol in subgroups on the basis of baseline concentrations and diabetes

The Indian Polycap Study (TIPS). Lancet 2009 Mar 30 [Epub]

Projected and estimated eff ects of a polypill, comparing estimates from Wald and Law6–8 versus that obtained in the Polycap study

The Indian Polycap Study (TIPS). Lancet 2009 Mar 30 [Epub]